phone icon  Toll Free : +1-800-792-5285 | (UK) : + 44-845-528-1300
Allied Market Research

0
Shopping Cart is Empty..
$ 0
CART  yellow arrow
 

Biomarkers are minimally or non-invasive tools used in imaging technology to provide clear imaging of oncology tumors & other problems and also eliminate the chance of radiation exposure during imaging through CT scans and MRI scans. Genomic biomarkers are used to test high blood pressure, hyperkalemia, and other monogenic conditions. They reflect the expression of a gene, function of a gene, and regulation of a gene in normal biologic processes, pathogenic processes, and responses to therapeutics.

The major factors that contribute to the growth of the genomic biomarkers market include increasing prevalence of ovarian, gastric, and colorectal cancers, high demand for minimally invasive procedures, development of technologies in clinical laboratory tests, immense developments in infrastructure for data sharing and analysis such as bioinformatics, and growing awareness about genomics biomarker-based personalized medicines.

However, complex processes associated with genomics biomarker and stringent government regulations hamper the growth of the global genomic biomarkers market. Growing awareness about the role of biomarkers to diagnose fatal diseases such as cancer and cardiovascular diseases & reimbursement issues are being solved with the intervention of regulatory authorities, which is expected to propel the growth of the market in the near future.

The global genomic biomarkers market is segmented on the basis of application, end user, and region. On the basis of application, the market is segmented into oncology, cardiovascular diseases, neurological diseases, and others. On the basis of end user, the market is segmented into diagnostic & research laboratories, hospitals, and others. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Aepodia SA, Myriad Genetics, Inc., Eurofins Scientific, QIAGEN, Bio-Rad Laboratories, Inc., Genomic Health, Liquid Genomics, Epigenomics AG, and AROS Applied Biotechnology A/S.

Key Benefits

  • The study provides an in-depth analysis of the global genomic biomarkers market with current trends and future estimations to elucidate imminent investment pockets.
  • The report provides information about the current and upcoming trends in the global genomic biomarkers market from 2016 to 2023, which helps determine prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the global genomic biomarkers market has been provided.
  • Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
  • Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global genomic biomarkers market.

Genomic Biomarkers Market Key Segments:

By Application

  • Oncology
  • Cardiovascular diseases
  • Neurological diseases
  • Others

By End User

  • Diagnostic and research laboratories
  • Hospitals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1-800-792-5285 or send an email to sales@alliedmarketresearch.com

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 GENOMIC BIOMARKERS MARKET, BY APPLICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ONCOLOGY

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. CARDIOVASCULAR DISEASES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. NEUROLOGICAL DISEASES

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 GENOMIC BIOMARKERS MARKET, BY END USER 

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. DIAGNOSTIC & RESEARCH LABORATORIES

5.2.1. Market size and forecast

5.3. HOSPITALS

5.3.1. Market size and forecast

Chapter: 6 GENOMIC BIOMARKERS MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America genomic biomarkers market by application
6.2.5. North America genomic biomarkers market by end user

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe genomic biomarkers market by application
6.3.5. Europe genomic biomarkers market by end user

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Taiwan market size and forecast
6.4.3.7. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific genomic biomarkers market by application
6.4.5. Asia-Pacific genomic biomarkers market by end user

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast

6.5.4. LAMEA genomic biomarkers market by application
6.5.5. LAMEA genomic biomarkers market by end user

Chapter: 7 COMPANY PROFILES

7.1. THERMO FISHER SCIENTIFIC INC.

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. F. HOFFMANN-LA ROCHE AG

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. AEPODIA SA

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. MYRIAD GENETICS, INC.

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. EUROFINS SCIENTIFIC

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. QIAGEN

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. BIO-RAD LABORATORIES, INC.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. GENOMIC HEALTH

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. EPIGENOMICS AG

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. AROS APPLIED BIOTECHNOLOGY A/S

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
License Type
Data Pack
Single User PDF
Five User Online/PDF
Enterprise Online/PDF
LICENSE INFO
Users/Sharing
Restricted to one authorized user

Restricted to one authorized user

Limited to 5 authorized users


Unlimited within company / enterprise
Printing
One Print only

One Print only
Up to Five Copies
Unlimited within company / enterprise
Delivery Formats
ADDED BENIFITS
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
Speak with analyst
connect
Did you miss anything?
To add more
request

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to eliminate redundant information to provide valued information and save time of the reader

 

Featured Readings



Dec 2013

Biomarkers Market- Global Opportunity Analysis and Industry Forecast, 2013 - 2020



May 2014

Bioinformatics Market- Global Opportunity Analysis and Industry Forecast, 2013 - 2020



Aug 2015

Cardiac Biomarkers Market- Global Opportunity Analysis and Industry Forecast, 2014 - 2020



Feb 2015

Small Animal Imaging (In-Vivo) Market- Global Opportunity Analysis and Industry Forecast, 2013 - 2020



Sep 2017

Metabolomics Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

Further Readings



Oct 2017

Biochip Products and Services Market- Global Opportunity Analysis and Industry Forecast, 2017-2023



Oct 2017

World Renal Biomarkers Market- Opportunities and Forecasts, 2017-2023



Oct 2017

Cytogenetics Market- Global Opportunity Analysis and Industry Forecast, 2017-2023



Oct 2017

Transcriptomics Market- Global Opportunity Analysis and Industry Forecast, 2017-2023



Oct 2017

Laboratory Automation Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

 

Get fresh content delivered

Get insights on topics that matter to your business. Stay updated on the areas that interest you.

About
US
Find
HELP
Consulting &
CUSTOM STUDIES
Our
PRODUCTS
Our
SERVICES
Press
MEDIA
STAY WITH US

fb blogger linkedin Gplus twitter Youtube Rss

WE ACCEPT


weAccept